Medigene (MDG1) News Today €1.03 -0.02 (-1.90%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period PTA-News: Medigene AG: Medigene AG reicht Antrag auf klinische Prüfung in Europa für MDG1015 für mehrere solide Tumorindikationen einDecember 18, 2024 | finanznachrichten.dePTA-News: Medigene AG: Umstrukturierung / PersonalabbauNovember 26, 2024 | finanznachrichten.deMedigene AG Announces Refocus of Corporate Strategy and Organizational RealignmentNovember 26, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene präsentiert Daten zu innovativer IFN-Gamma-Biosensor-Technologie bei SITC 2024November 13, 2024 | finanznachrichten.deMedigene Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024November 13, 2024 | markets.businessinsider.comPTA-News: Medigene AG: Medigene präsentiert neuste Daten zur UniTope- und TraCR-Technologie auf der PEGS- und SITC-Konferenz 2024November 11, 2024 | finanznachrichten.deMedigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024November 11, 2024 | markets.businessinsider.comMedigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024November 8, 2024 | finance.yahoo.comCan Medigene (ETR:MDG1) Afford To Invest In Growth?November 6, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene AG veröffentlicht Geschäftszahlen und Business Update für Q3 2024October 24, 2024 | finanznachrichten.deMedigene AG reports Financial Results and Business Update for Q3 2024October 24, 2024 | tmcnet.comMedigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024October 17, 2024 | markets.businessinsider.comPTA-News: Medigene AG: Medigene präsentiert auf folgenden wissenschaftlichen KonferenzenOctober 16, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene präsentiert auf der ASGCT 2024 und hält F&E-Veranstaltung abOctober 2, 2024 | finanznachrichten.deMedigene will Present at ASGCT 2024 and Host R&D EventOctober 2, 2024 | markets.businessinsider.comFormycon AG (FYB.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.com4SC AG (VSC.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comMedigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision ImmunotherapiesSeptember 16, 2024 | markets.businessinsider.comMedigene AG (MDG1.SG)August 29, 2024 | nz.finance.yahoo.comMedigene AG (MDG1.MU)August 29, 2024 | nz.finance.yahoo.comMedigene AG (MDG1.VI)August 29, 2024 | uk.finance.yahoo.comMedigene AG (MDG1.HM)August 29, 2024 | nz.finance.yahoo.comMedigene to Present at Upcoming Investor ConferencesAugust 28, 2024 | markets.businessinsider.comMedigene Second Quarter 2024 Earnings: Beats ExpectationsAugust 17, 2024 | finance.yahoo.comMunich Re sees market volatility to continue for weeks or monthsAugust 9, 2024 | uk.finance.yahoo.comWuXi Biologics and Medigene link on T cell engagers for cancerAugust 9, 2024 | finance.yahoo.comMedigene AG (MDG1.BE)July 30, 2024 | sg.finance.yahoo.comMedigene to Present at ESMO Congress 2024July 23, 2024 | markets.businessinsider.comMedigene AG: Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRASMay 15, 2024 | finanznachrichten.deMedigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRASMay 15, 2024 | finance.yahoo.comMedigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital RaiseMay 14, 2024 | finance.yahoo.comMedigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch ProteinMay 2, 2024 | markets.businessinsider.comMedigene AG reports Financial Results and Business Update for Q1 2024April 26, 2024 | finance.yahoo.comMedigene presents streamlined 6-day, high stemness TCR-T therapy production processApril 25, 2024 | finance.yahoo.comPTA-Adhoc: Medigene AG: Medigene AG führt Bezugsrechtskapitalerhöhung mit Backstop-Vereinbarung durchApril 22, 2024 | finanznachrichten.deMedigene to Present at Upcoming Scientific ConferencesApril 17, 2024 | finance.yahoo.comMedigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024April 8, 2024 | finance.yahoo.comMedigene: 2024 steht im Zeichen von MDG1015, BioNTech und der FinanzierungApril 4, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG sichert sich europäisches Patent für ihre iM-TCR-TechnologieApril 4, 2024 | finanznachrichten.deMedigene AG Secures European Patent for its iM-TCR TechnologyApril 4, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene AG gibt Finanzergebnisse für das Geschäftsjahr 2023 und Unternehmens-Update bekanntMarch 28, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG gibt -2-March 28, 2024 | finanznachrichten.deWe Think Medigene (ETR:MDG1) Needs To Drive Business Growth CarefullyMarch 26, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene AG nimmt an der H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference teilMarch 19, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG veröffentlicht Finanzergebnisse für das Geschäftsjahr 2023 am 28. März 2024March 18, 2024 | finanznachrichten.deMedigene AG to report full year 2023 financial results on March 28, 2024March 18, 2024 | finance.yahoo.comMedigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual MeetingMarch 6, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene erweitert Patentportfolio in Japan um iM-TCR-Technologie zur Kontrolle der TCR-T-Sicherheit und -WirksamkeitMarch 4, 2024 | finanznachrichten.deMedigene AG: Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T TherapiesFebruary 29, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene zeigt auf dem CAR-TCR Summit Europe innovative Ansätze zur Entwicklung differenzierter TCR-T-TherapienFebruary 29, 2024 | finanznachrichten.de Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW MDG1 Media Mentions By Week MDG1 Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDG1 News Sentiment▼0.000.60▲Average Medical News Sentiment MDG1 News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDG1 Articles This Week▼11▲MDG1 Articles Average Week Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genfit News Today MorphoSys News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Sanofi News Today Sartorius Stedim Biotech News Today Siemens Healthineers News Today Bayer Aktiengesellschaft News Today Merck KGaA News Today Fresenius Medical Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MDG1) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medigene AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Medigene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
